active

A unique collection of 3188 compounds with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 2427 of orally active compounds for high-throughput screening and high-content screening.

A collection of 25218 bioactive compounds for high-throughput screening, high-content screening, cell induction and target identification.

A collection of 17100 small molecule compounds with validated activity for high throughput screening (HTS), high content screening (HCS), cell induction, and target identification;

It is well-selected from Bioactive compound library Plus (D7800), from which 1-15 compounds with the highest scores (activity value, pharmacological properties, structure-diversity, etc.) were chosen. This library consists of 989 compounds without compro

A Collection of 182 inactive ingredients from FDA-approved drugs.

A unique collection of 385 bioactive lipids related compounds for high throughput screening (HTS) and high content screening (HCS), including Agonists & Antagonists, Endocannabinoids, Farnesyl geranylgeranyl derivates, HETEs deHETEs, hepoxilins, Polyunsa

A unique collection of 1940 GPCR-active agents for high throughput screening and high content screening for GPCR drug discovery, and new GPCR target identification and research;

A collection of 747 natural product molecules originated from Tibetan medicine, which can be used for high-throughput and high-content screening.

A collection of 499 selected human endogenous metabolites for high throughput and high content screening.

A unique collection of 500 natural alkaloids can be used for high throughput and high content screening；

A unique collection of 514 flavonoids can be used for high throughput and high content screening；

A unique collection of 2755 compounds (TCM monomers) sourcing from traditional Chinese Medicines, is a powerful tool for drug discovery and research in mechanism；

A unique collection of 334 nucleoside and nucleotide analogues, can be used for research and development of anti-viral, anti-tumor, anti-fungal, and anti-depressive drugs;

Well-chosen 338 GPCR targeting compounds with unique structures;

A unique collection of 2051 natural products included in Chinese Pharmacopoeia (CP), a powerful tool for drug development and pharmacological study;

A unique collection of 580 compounds derived from traditional Chinese medicines (TCMs) for promoting blood circulation and removing blood stasis.

A unique collection of 693 rare natural products, which can be used for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 574 fluorochemicals that can be used for high through-put screening (HTS) and high content screening (HCS);

Structurally diverse, medicinally active, and unique chemistry (strong IP potential);